A new study suggests there is an association between taking the active drug in Ozempic and Wegovy, and the development of condition that causes blindness. Health reporter Katherine Ward has more from doctors about the rare condition, and what people taking the drug should know.
Health
Semaglutide associated with blindness risk, study suggests
More Videos
-
Emergency room doctors raise concerns about e-scooters
-
Health Matters: Safety standards group calls for new long-term mental health care supports
-
Honouring and supporting Disability Pride Month
-
Calls from Heart and Stroke Foundation grow to regulate food advertising to kids
-
Health Matters: Class-action lawsuit filed over plant-based milk listeria outbreak
-
Upgrading Ontario’s 911 Emergency Response System
You are viewing an Accelerated Mobile Webpage.
View Original Article